ArticleScientific reports2026
Sustainable CO
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study developed resilient mixed microbial cultures (MMCs) from diverse indigenous sources 2 through strategic pretreatment and enrichment, robust conversion of CO2 and bicarbonate into volatile fatty acids (VFAs) and polyhydroxybutyrate (PHB) was achieved. This article establishes a sustainable biotechnological platform, transforming waste CO2 into valuable bio-products and biodegradable polymers, thereby bridging a circular bioeconomy approach. In Phase I, CO2 was converted into VFAs (2.017, 2.307, 3.243, and 3.467 g/L) by anaerobic MMC and PHB (3.2% (0.082 g/L)) by aerobic cultures, respectively.The reduction in pH was observed to 3.45 ± 0.22 due to pretreatment methods, indicated acetogenic dominance. In phase II, VFA was recirculated for PHB production (6.5 ± 0.24%) and molecular confirmation was done using FTIR and NMR.ted The anaerobic MMC achieved a CO2 reduction efficiency of 70 ± 1.78%, while aerobic cultures showed 45 ± 1.26%, contributing to the production of biodegradable PHB, thus closing loop towards circular bio-economy. This study also shows carbon balance and thermodynamic feasibility of converting CO₂ into PHB via microbial fermentation, highlighting the energy requirements and process efficiency. Metagenomic analysis of microbial consortia, using 16S rRNA (V3-V4) sequencing, identified key bacteria for CO2 bioconversion. Anaerobic genera like Pseudomonas and Halomonas dominated VFA production, while aerobic bacteria such as Brevundimonas, Achromobacter were predominant in PHB synthesis. KEGG analysis predicts genetic pathways for CO2 fixation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.